Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Onconetix (ONCO) Gross Margin (2024 - 2025)

Historic Gross Margin for Onconetix (ONCO) over the last 2 years, with Q3 2025 value amounting to 88.55%.

  • Onconetix's Gross Margin rose 626400.0% to 88.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 85.41%, marking a year-over-year change of. This contributed to the annual value of 41.8% for FY2024, which is 19697300.0% up from last year.
  • Latest data reveals that Onconetix reported Gross Margin of 88.55% as of Q3 2025, which was up 626400.0% from 66.2% recorded in Q2 2025.
  • Over the past 5 years, Onconetix's Gross Margin peaked at 92.7% during Q4 2024, and registered a low of 14.29% during Q2 2024.